Mechanistic Effects of Semaglutide on Kidney Disease in Type 2 Diabetes: The REMODEL Trial
Authors:
Katherine R. Tuttle1,2; Petter Bjornstad3,4; Menno Pruijm5; Jeffrey B. Hodgin6; David Z.I. Cherney7; Nicolas Belmar8; Milenta Mariam Chacko9; Vivek Das8; Thomas Idorn8; Philip A. Schytz8; Matthias Kretzler10